Back to search results

DSLT Performance for Newly Diagnosed Open Angle Glaucoma

This observational study is looking at how well a procedure called DSLT (which helps newly diagnosed patients stay well-controlled and off medications) works for people with Open Angle Glaucoma (OAG). The study aims to see if DSLT can reduce eye pressure by at least 20% from the start of treatment. You might be able to join if you are 30 or older, have primary open angle glaucoma with eye pressure between 18-26 mmHg, and have mild to moderate glaucoma. You cannot have had any prior glaucoma treatment, including medications, lasers, or surgery. The study plans to include 55 participants, but its current recruitment status is unclear.

Study design
This is an observational study with a planned enrollment of 55 participants. It is not specified if it's randomized or blinded.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
The primary endpoint measures success of IOP reduction at 12 months, suggesting participants will be followed for at least one year.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06933836

DSLT Performance in Treatment-naïve Patients With Newly Diagnosed Open Angle Glaucoma

Recruiting
Not specifiedAges 30+Observational
Barnet Dulaney Perkins Eye Centers
~55 participants
Updated 2025-04-18 on ClinicalTrials.gov
What's tested:DSLT enables newly diagnosed patients to remain well controlled and off medications

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Success of IOP Reduction Through DSLT Utilization
Measured over 12 months

Conditions

Open Angle Glaucoma (OAG)

Explore related trials

Primary Open Angle Glaucoma

Where it's being run

1 sites across 1 states
Arizona1

Study leadership

  • Christine Funke, Medical Doctor · PRINCIPAL_INVESTIGATOR · Barnet Dulaney Perkins Eye Centers

Who to contact

Derek J Arnson, Master of Education
[email protected]
4804201005
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Primary open angle glaucoma
Patients age 30 or greater with an IOP of 18-26 mmHg
Mild to moderate POAG patients (mild or moderate according to the AAO PPP Guidelines)
DSLT procedure

Exclusion

History of prior glaucoma treatment - this includes past medication use (in either eye), previous lasers or incisional surgery
Angle closure patients
Ocular Hypertension
Baseline VF MD of worse than -12dB
Uncontrolled systemic microvascular disease (eg. HTN, DM)
Subjects with peri-limbal findings (e.g. melanosis, tumors, extensive pterygium, significant senile arcus and pterygium)

What this trial measures

  • Success of IOP Reduction Through DSLT Utilization12 months

    Proportion of patients (%) with DSLT success as defined as IOP lowering of \>20% and no additional medications or procedures at 12 months.